You are here

Coronary Intervention & Surgery

 

Boston Scientific’s transcatheter aortic valve implantation (TAVI) technology, the LOTUS Valve System, shows superiority to a similar platform made by a competitor in a new clinical trial.

On the 50th anniversary of using heart transplantation to save lives, researchers from the Pitié-Salpêtrière Hospital in Paris revealed a technique that could reduce the risk of patients rejecting donor hearts.

A database analysis in New York found that the mitral valve case volume of individual surgeons had a significant impact on patient outcomes following surgery.

The U.S. Food and Drug Administration (FDA) approved the Resolute Onyx drug-eluting stent for adults with coronary artery disease.

Researchers in Germany have developed a risk prediction score that strongly correlated with mortality in patients who suffer from cardiogenic shock following an acute MI.

 

Recent Headlines

Boston Scientific’s TAVI system exceeds expectations in clinical trial

Boston Scientific’s transcatheter aortic valve implantation (TAVI) technology, the LOTUS Valve System, shows superiority to a similar platform made by a competitor in a new clinical trial.

SCAI 2017: TAVR outcomes depend on individual risk factors, not valve type

A late-breaking study, presented May 12 at the Society of Cardiovascular Angiography and Interventions meeting in New Orleans, showed that factors related to individual patients—and not the specific type of valve used—determined 30-day outcomes for transcatheter aortic valve replacement (TAVR).

SCAI 2017: Robotic PCI highly successful with transradial, transfemoral access

The May 12 late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions in New Orleans compared femoral and radial robotic percutaneous coronary intervention (PCI) procedures.

Researchers reduce donor heart rejection with desensitizing antibodies

On the 50th anniversary of using heart transplantation to save lives, researchers from the Pitié-Salpêtrière Hospital in Paris revealed a technique that could reduce the risk of patients rejecting donor hearts.

Patients with degenerative mitral valve disease see better results with experienced surgeons

A database analysis in New York found that the mitral valve case volume of individual surgeons had a significant impact on patient outcomes following surgery.

Communication, coordination among hospital leaders and physicians improve surgical outcomes

In October 2010, some hospitals in South Carolina began implementing a customized surgical safety checklist patterned after a checklist that the World Health Organization developed. Hospitals implemented the 12-step process that focused on teamwork, training and monitoring progress.

SCAI announces late-breaking clinical trials sessions

The Society for Cardiovascular Angiography and Interventions (SCAI) recently announced the late-breaking clinical trials sessions for the SCAI 2017 scientific sessions.

FDA approves Medtronic’s Resolute Onyx drug-eluting stent

The U.S. Food and Drug Administration (FDA) approved the Resolute Onyx drug-eluting stent for adults with coronary artery disease.

Risk score may help predict mortality in cardiogenic shock patients

Researchers in Germany have developed a risk prediction score that strongly correlated with mortality in patients who suffer from cardiogenic shock following an acute MI.

Cardiologist treats first patient in study evaluating orbital atherectomy system

Cardiovascular Systems recently announced the first patient had enrolled in the company’s ECLIPSE trial, which is evaluating its Diamondback 360 coronary orbital atherectomy system.

Pages